Effect of prostate manipulation on the serum levels of complexed prostate-specific antigen and total prostate-specific antigen

International Journal of Urology

Volumn 13, Issue 7, 2006, Pages 947-950

  Long, Ronan ^a,c   Giri, Subhasis ^a   Diver, Sean ^a   Duddy, Lorna ^a   Mckeown, Declan ^b   Moran, Kevin ^a  

^a LETTERKENNY GENERAL HOSPITAL   (Ireland)

^b Merlin Park University Hospital   (Ireland)

^c NONE   (Ireland)

Author keywords

Complexed prostate specific antigen; Cystoscopy; Prostate biopsy; Prostate specific antigen; Transurethral resection of the prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; CYSTOSCOPY; DIGITAL RECTAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE; PROSTATE BIOPSY; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; TRANSURETHRAL RESECTION;

EID: 33745927118     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01445.x     Document Type: Article

References (29)

1. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery - what we have learned and where we are going. J. Urol. 1999; 162: 293-306.
2. Catalona WJ, Smith DS, Ratliff TL et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer (Comment). (Published erratum appears in N. Engl. J Med. 1991; 325: 1324.) N. Engl. J. Med. 1991; 324: 1156-61.
3. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH. Screening for prostatic carcinoma with prostate specific antigen. J. Urol. 1992; 147 (3 Part 2): 841-5.
4. Benson M, Whang IS, Olsson CA et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol. 1992; 147: 817-21.
5. Kalish J, Cooner WH, Graham SD. Serum PSA adjusted for volume of transition zone (PSAD) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 1994; 43: 601-6.
6. Zlotta AR, Djavan B, Marberger M et al. Prostate specific antigen density of transition zone a new effective parameter for prostate cancer prediction. J. Urol. 1997; 157: 1315-21.
7. Oesterling JE, Jacobsen SJ, Chute CG et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges (Comment). JAMA 1993; 270: 860-4.
8. Catalona WJ, Smith DS, Wolfert RL et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening (Comment). JAMA 1995; 274: 1214-20.
9. Okegawa T, Kinjo M, Watanabe K et al. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL. BJU Int. 2000; 85: 708-14.
10. Lilja H, Christensson A, Dahlen U et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin. Chem. 1991; 37: 1618-25.
11. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 1991; 51: 222-6.
12. Christensson A, Lilja H. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur. J. Biochem. 1994; 220: 45-53.
13. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem. 1990; 194: 755-63.
14. Martinez M, Espana F, Royo M et al. The proportion of prostate-specific antigen (PSA) complexed to alpha (1)-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10-30 microg/L. Clin. Chem. 2002; 48: 1251-6.
15. Mitchell ID, Croal BL, Dickie A, Cohen NP, Ross I. A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer. J. Urol. 2001; 165: 1549-53.
16. Tello FL, Prats CH, Gonzalez MD. Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer. Clin. Chem. Lab. Med. 2001; 39: 116-20.
17. Miller MC, O'Dowd GJ, Partin AW, Veltri RW. Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics. Urology 2001; 57: 1105-11.
18. Jung K, Elgeti U, Lein M et al. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? Clin. Chem. 2000; 46: 55-62.
19. Horninger W, Cheli CD, Babaian RJ et al. Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2-4 nanograms per milliliter. Urology 2002; 60 (4 Suppl 1): 31-5.
20. Maeda H, Arai Y, Aoki Y, Okubo K, Okada T, Maekawa S. Complexed prostate-specific antigen and its volume indexes in the detection of prostate cancer. Urology 1999; 54: 225-8.
21. Taneja SS, Hsu EI, Cheli CD et al. Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis. Urology 2002; 60 (4 Suppl 1): 10-17.
22. Ellison L, Cheli CD, Bright S, Veltri RW, Partin AW. Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screening. Urology 2002; 60 (4 Suppl 1): 42-6.
23. Yuan JJ, Coplen DE, Petros JA et al. Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. J. Urol. 1992; 147 (3 Part 2): 810-14.
24. Thomson RD, Clejan S. Digital rectal examination-associated alterations in serum prostate-specific antigen. Am. J. Clin. Pathol. 1992; 97: 528-34.
25. Crawford ED, Schutz MJ, Clejan S et al. The effect of digital rectal examination on prostate-specific antigen levels. JAMA 1992; 267: 2227-8.
26. Oesterling JE, Rice DC, Glenski WJ, Bergstralh EJ. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum pro state-specific antigen concentration. Urology 1993; 42: 276-82.
27. Chybowski FM, Bergstralh EJ, Oesterling JE. The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study. J. Urol. 1992; 148: 83-6.
28. Ornstein DK, Rao GS, Smith DS, Ratliff TL, Basler JW, Catalona WJ. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels. J. Urol. 1997; 157: 195-8.
29. Lynn NN, Collins GN, O'Reilly PH. Prostatic manipulation has a minimal effect on complexed prostate-specific antigen levels. BJU Int. 2000; 86: 65-7.